MFDS
- Status: likely_approved
🇰🇷 Inmazeb in South Korea
Inmazeb (ODESIVIMAB) regulatory status in South Korea.
Marketing authorisation
Inmazeb in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Inmazeb approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Inmazeb in South Korea?
Regeneron is the originator. The local marketing authorisation holder may differ — check the official source linked above.